VectivBio Announces Results of Extraordinary General Meeting-Wouter Joustra Elected to the Board of Directors
VectivBio Holding AG , a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announced today that Wouter Joustra was elected as a new... | December 12, 2022